Hepatic rejection after orthotopic liver transplantation for hepatic veno-occlusive disease or graft-versus-host disease following bone marrow transplantation.
Adult; Bone Marrow Transplantation/adverse effects; Child, Preschool; Graft Rejection/mortality; Graft vs Host Disease/etiology/mortality/surgery; Hepatic Veno-Occlusive Disease/etiology/mortality/surgery; Humans; Liver Transplantation; Male
Disciplines :
Hematology
Author, co-author :
Dowlati, A.
Honore, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Chirurgie abdominale- endocrinienne et de transplantation
Damas, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Soins intensifs
Deprez, Manuel ; Université de Liège - ULiège > Département des sciences cliniques > Neuropathologie
Delwaide, Jean ; Centre Hospitalier Universitaire de Liège - CHU > Gastro-Entérologie-Hépatologie
Fillet, Georges ; Centre Hospitalier Universitaire de Liège - CHU > Hématologie clinique
Beguin, Yves ; Centre Hospitalier Universitaire de Liège - CHU > Hématologie clinique
Language :
English
Title :
Hepatic rejection after orthotopic liver transplantation for hepatic veno-occlusive disease or graft-versus-host disease following bone marrow transplantation.
Publication date :
1995
Journal title :
Transplantation
ISSN :
0041-1337
eISSN :
1534-6080
Publisher :
Lippincott Williams & Wilkins, Hagerstown, United States - Maryland
McDonald GB, Shulman HM, Wolford JL, Spencer GD. Liver disease after human marrow transplantation. Semin Liver Dis 1987; 7: 210.
Shulman HM, McDonald GB. Liver disease after marrow trans plantation. In: Sale GE, Shulman HM, eds. The pathology of bone marrow transplantation. New York: Masson, 1984: 104.
Rhodes DF, Lee WH, Wingard JR, et al. Graft-versus-host dis ease following bone marrow transplantation. Gastroenterology 1990; 99: 536-538.
Marks DI, Dousset B, Robson A, et al. Orthotopic liver trans plantation for hepatic GVHD following allogeneic BMT for chronic myeloid leukemia. Bone Marrow Transplant 1992; 10: 463.
Nimer SD, Milewicz, Champlin RE, Busuttil W. Successful treatment of hepatic veno-occlusive disease in a bone marrow transplant patient with orthotopic liver transplantation. Transplantation 1990; 49: 819.
Rapoport AP, Doyle MR, Starzl T, Rowe JM, Dreblin T, di Persio JF. Orthotopic liver transplantation for life threatening veno-occlusive disease of the liver after allogeneic bone marrow transplant. Bone Marrow Transplant 1991; 8: 421.
Coiťĭĩer B, Gisselbrecht C, Herbrecht R, Tilly H, Bosly A, Brousse N. LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma. J Clin Oncol 1989; 7: 1018.
Souza LM, Boone TC, Gabrilove J, et al. Recombinant human granulocyte colony stimulating factor: effects on normal and leukemic myeloid cells. Science 1986; 232: 61.
Welte K, Bonilla MA, Gillio AP, et al. Recombinant human granulocyte colony-stimulating factor. J Exp Med 1987; 165: 941.
Clark SC, Kamen R. The human hematopoietic colony stimulating factors. Science 1987; 236: 1229.
Braun WE. Molecular, genetic and clinical aspects of the HLA system. In: Cerilli GJ, ed. Organ transplantation and replacement. Philadelphia: JB Lippincott, 1988: 162.
Coldumoun SD, Shaked A, Jurim O, Colonna JO, Rosove MH, Busuttil RW. Reversal of neutropenia with granulocyte colony-stimulating factor without precipitating liver allograft rejection. Transplantation 1993; 56(6): 1593.
